Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SBFMW | US
-0.00
-0.96%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
0.10
0.10
0.10
0.10
Sunshine Biopharma Inc. a pharmaceutical company focuses on the research and development of life-saving medicines in various therapeutic areas including oncology and antivirals. The company is developing Adva-27a a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia lymphoma testicular lung brain prostate bladder colon ovarian liver and other forms of cancers as well as kills multidrug resistant cancer cells including pancreatic cancer breast cancer small-cell lung cancer and uterine sarcoma cells; SBFM-PL4 an anti-coronavirus treatment compound; and K1.1 mRNA molecules used as anti-cancer agents. It also offers Essential 9 an amino acids capsules; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name as well as develops and markets other science-based nutritional supplements. Sunshine Biopharma Inc. is based in Pointe-Claire Canada.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
445.3%1 month
385.1%3 months
349.5%6 months
349.6%-
-
-
0.02
0.02
-
-
-
-4.40M
-
-
-
-13.63
-
67.30
-15.79
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.14
Range1M
0.16
Range3M
0.19
Rel. volume
0.37
Price X volume
651.58
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Biofrontera Inc. Warrants | BFRIW | Drug Manufacturers-Specialty & Generic | 0.02 | 0 | n/a | 13.20% | |
Alvotech Warrant | ALVOW | Drug Manufacturers-Specialty & Generic | 2.98 | 0 | n/a | -196.14% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 14.17 | 0 | 0.78% | n/a |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 17.21 | - |
Ent. to Revenue | - | 334.38 | - |
PE Ratio | - | 26.92 | - |
Price to Book | - | 12.15 | - |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 349.48 | 68.34 | Riskier |
Debt to Equity | 0.02 | -1.00 | Expensive |
Debt to Assets | 0.02 | 0.48 | Cheaper |
Market Cap | - | 5.31B | - |